Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Kihara currently holds 27,865 shares of ACADIA PHARMACEUTICALS INC (ACAD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Kihara has been a net seller of ACAD stock. They have purchased $0 and sold $586.2K worth of shares.
James Kihara's most recent insider trade was on Apr 7, 2026, when they sold 1,030 shares at $22.20 per share.
James Kihara serves as Executive at ACADIA PHARMACEUTICALS INC (ACAD). They have executed 41 insider transactions totaling $586.2K over their tenure at the company.
James Kihara holds the position of Executive at ACADIA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
James Kihara has shown a selling trading pattern, with $0 in total purchases and $586.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James Kihara was on May 17, 2023, when they sold $133.8K worth of ACAD shares. This transaction involved 5,947 shares at $22.50 per share.
James Kihara currently owns 27,865 shares of ACADIA PHARMACEUTICALS INC (ACAD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Kihara's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Kihara has 41 Form 4 filings on record as an insider at ACADIA PHARMACEUTICALS INC.
Set alerts for James Kihara and 40,000+ other insiders.